EQT to Acquire Majority Interest in Aldevron - the Leading Global Supplier of Plasmid DNA Used in Cell and Gene Therapies

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/3334Ou6
via IFTTT